All stock lists
Unlock the score
Tenax Therapeutics, Inc. (TENX)
United States · Delayed Price · Currency is USD
Pharmaceutical Preparations
1.67-0.05 (-3.20%)
Insider Score
Insider Score
/ 100
TENX Insider Score
TENAX THERAPEUTICS, INC. has a live Insider Score.
Scored on 4 qualifying trades from 3 insiders in the last 90 days.
TENX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 5.93 M | 5.03 M | 5.91 M | 6.48 M | 5.67 M | — |
| R&D Expense | 12.85 M | 11.54 M | 10.54 M | 10.33 M | 6.12 M | — |
| Operating Expenses | 18.78 M | 16.57 M | 16.45 M | 16.81 M | 11.79 M | — |
| Operating Income | -18.78 M | -16.57 M | -16.45 M | -16.81 M | -11.79 M | — |
| Pretax Income | -17.80 M | -15.72 M | -15.54 M | -15.80 M | -10.85 M | — |
| Tax Provision | — | — | — | — | — | — |
| Net Income | -17.80 M | -15.72 M | -15.54 M | -15.80 M | -10.85 M | — |
| EPS (Basic) | -0.35 | -0.35 | — | -0.40 | -0.27 | -0.28 |
| EPS (Diluted) | -0.35 | -0.35 | — | -0.40 | -0.27 | -0.28 |
| Shares Outstanding | 50.87 M | 45.23 M | — | 39.74 M | 39.57 M | 36.58 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.